Skip to Content

Tobii Dynavox AB H3Q

Morningstar Rating
€4.97 −0.10 (1.88%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

H3Q is trading at a 828% premium.
Price
€4.96
Fair Value
€4.24
Uncertainty
High
1-Star Price
€6.28
5-Star Price
€5.69
Economic Moat
Dgsb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if H3Q is a good fit for your portfolio.

Trading Information

Previous Close Price
€5.06
Day Range
€4.974.97
52-Week Range
€1.595.30
Bid/Ask
€0.00 / €0.00
Market Cap
€520.59 Mil
Volume/Avg
0 /

Key Statistics

Price/Earnings (Normalized)
52.17
Price/Sales
3.58
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Tobii Dynavox AB is engaged in the assistive technology for communication. The company's custom designed solutions enable people with disabilities such as cerebral palsy, ALS and spinal cord injury to communicate with a voice of their own, develop literacy skills and live more independently. Tobii integrated solutions include hardware, software, clinically developed language systems, special education tools, training, and dedicated support.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
700

Comparables

Valuation

Metric
H3Q
FNOX
BICO
Price/Earnings (Normalized)
52.1763.95
Price/Book Value
18.0720.361.02
Price/Sales
3.5822.501.42
Price/Cash Flow
21.0251.52
Price/Earnings
H3Q
FNOX
BICO

Financial Strength

Metric
H3Q
FNOX
BICO
Quick Ratio
0.891.681.74
Current Ratio
1.151.732.52
Interest Coverage
3.67−20.02
Quick Ratio
H3Q
FNOX
BICO

Profitability

Metric
H3Q
FNOX
BICO
Return on Assets (Normalized)
6.99%24.06%−4.62%
Return on Equity (Normalized)
39.40%38.23%−7.26%
Return on Invested Capital (Normalized)
15.24%33.69%−6.72%
Return on Assets
H3Q
FNOX
BICO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
GfhcdbbdZpcq$151.0 Bil
Becton Dickinson & Co
BDX
KncqndrSkbfbj$67.5 Bil
Alcon Inc
ALC
RygcfbzgWdbrdz$44.4 Bil
ResMed Inc
RMD
YrgzspwbsyKqjfld$31.1 Bil
Coloplast A/S ADR
CLPBY
MdrtbszysDfgcx$27.6 Bil
West Pharmaceutical Services Inc
WST
HllwygrkrDshx$24.4 Bil
The Cooper Companies Inc
COO
XglblpctyRcqnnff$18.6 Bil
Baxter International Inc
BAX
TvnyqnqtFrhywq$17.2 Bil
Hologic Inc
HOLX
RqvjwwnytRlmzcb$16.8 Bil
Teleflex Inc
TFX
DxdhyBqyk$9.8 Bil

Sponsor Center